Fem-Dophilus^® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1^® and Lactobacillus reuteri, RC-14^®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1^® and RC-14^® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus^® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*

Fem-Dophilus^® does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77°F (25°C).

GR-1^®/RC-14^® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1^®/RC-14^® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Martinez, et al. Can J Microbiol 2009;55:133-138